Navigation Links
ARIUS recognized for entrepreneurial excellence
Date:4/7/2008

ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com.

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements in this release include, but are not limited to, ARIUS successfully advancing its new product programs as well as licensing opportunities. These statements are only predictions and actual events or results may differ materially. Factors that could cause such actual events or results expressed or implied by such forward-looking statements to differ materially from any future results expressed or implied by such statements include, but are not limited to: early stage of development; technology and product development; dependence on and management of current and future corporate collaborations; future capital needs; uncertainty of additional funding; no assurance of market acceptance; dependence on proprietary technology and uncertainty of patent protection; intense competition; manufacturing and market uncertainties; and government regulation. These and other factors are described in detail in ARIUS' Annual Report, forthcoming news releases and other filings with Canadian securities regulatory authorities available at http://www.sedar.com. Forward-looking statements are based on our current expectations and ARIUS is not obligated to update such information to reflect later events or developments.


'/>"/>
SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
2. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
3. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
4. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
5. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
6. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
7. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
8. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
9. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
10. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
11. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015   GenoSpace , ... the interpretation and analysis of genomic and other ... has joined the company as Vice President ... http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace partners ... integrate, interpret, analyze and explore complex sets of ...
(Date:7/30/2015)... Diego , CA (PRWEB) , ... July 30, ... ... announced the successful completion of a field clinical study of its canine osteoarthritis ... developed together with Aratana Therapeutics (Kansas City, KS) and will be marketed in ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/30/2015)... NH (PRWEB) , ... July 30, 2015 , ... ... homogenizer for advanced fluid applications and designed for continuous operation up to 1500 ... and sterilization-in-place, ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
... May 24 Repligen Corporation (Nasdaq: RGEN ) ... the Food and Drug Administration (FDA) has granted orphan drug ... for the treatment of Friedreich,s ataxia.  Orphan drug designation qualifies ... the United States if the company is the first ...
... Ohio , May 24, 2010 Simbionix USA Corporation,the world,s ... the healthcare industry, is launching,two new hands-on training systems- the Lap Nepherctomy ... first time at,the AUA annual meeting in San Francisco next ... ...
... ( RBC Life Sciences : OTC Bulletin Board: RBCL) — RBC ... management products, announced today it has promoted Director of Sales Kevin Young ... , , , ... at a time when RBC Life Sciences is in the midst of a ...
Cached Biology Technology:Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia 2Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia 3Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia 4Simbionix to Reveal Two new Products at the Upcoming American Urology Association (AUA) Annual Meeting 2Simbionix to Reveal Two new Products at the Upcoming American Urology Association (AUA) Annual Meeting 3RBC Life Sciences Fills Newly Created Vice President of Sales and Marketing Position With Industry Veteran 2
(Date:7/31/2015)... China , 31 de julio de 2015 /PRNewswire/ ... Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 de ... . La conferencia celebra su décimo aniversario ... ha convertido en una de las reuniones anuales más ... y es una de las conferencias científicas más dinámicas, ...
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/23/2015)... BEDFORD, Mass., July 23, 2015 Aware, Inc. (NASDAQ: ... services, today reported financial results for its second quarter ended ... quarter of 2015 was $4.5 million, a decrease of 33% ...  Net income in the second quarter of 2015 was $0.3 ... million, or $0.04 per diluted share, in the same period ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... international business executive, has made a gift to Princeton ... to problems of energy and the environment. Princeton will ... create the Gerhard R. Andlinger Center for Energy and ... Science. The Andlinger Center will include a ...
... University of Heidelberg founded in cooperation with the Japanese ... it possible for the first time to automatically reproduce ... important aid for researchers in understanding cancer or in ... and tissue. The Hamamatsu Tissue ...
... at Delft University of Technology (TU Delft) in The Netherlands ... silver and other metals. Surprisingly enough, these so-called super atoms ... same way as individual atoms and have opened up a ... read in the new edition of TU Delft magazine ...
Cached Biology News:Gift of $100 million to transform energy and environment research at Princeton 2Gift of $100 million to transform energy and environment research at Princeton 3Gift of $100 million to transform energy and environment research at Princeton 4Insights into micromillimeters 2Super atoms turn the periodic table upside down 2
... provides high-pressure tubing for use with ... chromatography systems. The kit includes precut ... PEEK tubing for the installation of ... running at flow rates less than ...
... thermal cycler holds 96 x 0.2 ml ... heated lid incorporates a thumbwheel to adjust ... vessels for oil-free cycling. Peltier heat pumps ... and ramping rates of up to 1.4 ...
... thermocycler provides maximum performance on minimum space. ... elements, high heating and cooling rates have ... times. With a maximum capacity of 48 ... the capacity of much more expensive 96 ...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
Biology Products: